Prazosin Hydrochloride Capsule shortage
To Be DiscontinuedPrazosin Hydrochloride Capsule is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.
Therapeutic category
Dosage form
Capsule
Routes
—
Last updated
04/28/2023
Strength variants
- Not specified
Need sourcing help for Prazosin Hydrochloride Capsule?
Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.
Connect with a sourcing partnerManufacturers reporting shortage
- Pfizer Inc.800-533-4535To Be Discontinued
- Pfizer Inc.800-533-4535To Be Discontinued
- Pfizer Inc.800-533-4535To Be Discontinued
Reason for shortage
ad slot 300x250
Related shortages in Cardiovascular
Lidocaine Hydrochloride Injection
- Category
- Cardiovascular
- Reason
- Not specified
- Updated
- 04/07/2026
Lidocaine Hydrochloride Injection
- Category
- Cardiovascular
- Reason
- Not specified
- Updated
- 04/07/2026
Lidocaine Hydrochloride Injection
- Category
- Cardiovascular
- Reason
- Not specified
- Updated
- 04/07/2026
Furosemide Injection
- Category
- Cardiovascular
- Reason
- Not specified
- Updated
- 04/06/2026
Bumetanide Injection
- Category
- Cardiovascular
- Reason
- Demand increase for the drug
- Updated
- 04/06/2026
Bumetanide Injection
- Category
- Cardiovascular
- Reason
- Demand increase for the drug
- Updated
- 04/06/2026
This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.